Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2025-12-24 @ 3:06 PM
NCT ID:
NCT04332159
Eligibility Criteria:
Inclusion Criteria:
* Being a man or a woman between 18 and 75 years old, inclusively ; and
* Being covered by the Quebec medical insurance (RAMQ); and
* Presenting an uncomplicated nasal fracture requiring a delayed (7 to 10 days) closed reduction.
Exclusion Criteria:
* Pregnant or breastfeeding woman; or
* Known for renal insufficiency (DFG \< 50) ; or
* Known for hepatic impairment; or
* Personal or familial allergies/hypersensitivity to fluorinated products; or
* Contraindications to local anesthesia (including allergies); or
* Personal or family history of malignant hyperthermia; or
* Other facial fractures and/or significant injuries; or
* Altered state of consciousness (dementia, drug intoxication, head trauma or other similar psychologic disorder); or
* Significant respiratory impairment; or
* Haemodynamic instability; or
* Simultaneous use of alcohol, isoniazid, phenobarbital, rifampin, opioids, sedatives, hypnotics, sedative antihistaminics, general anesthetics, phenothiazines, tranquilizers, myorelaxants, nephrotoxic antibiotics (tetracycline, gentamicin, colistine, polymyxin B, amphotericin B); or
* Use of cannabis or other illicit drugs the day of the procedure; or
* Use of pain medication in past 6 hours; or
* Use of Methoxyflurane : more than 6 mL in the last 48 hours or more than 15 mL in the last week or usage in the last 3 months; or
* Need of sedation or general anesthesia for the procedure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04332159
Study Brief:
Protocol Section:
NCT04332159